About this Activity
This program will provide clinicians with a thorough understanding of fibromyalgia as condition with an overlapping symptomatic, functional and pathophysiologic presentation with many other mood and medical conditions. Subsequently, participating in this activity will facilitate the clinician’s ability to render an early and accurate diagnosis of fibromyalgia and implement an integrative approach to effective management.

Learning Objectives
By participating in this symposium, learners will be able to:

• Understand the pathophysiology of fibromyalgia.
• Indentify challenges in the diagnosis of fibromyalgia including overlapping symptomatology and comorbid conditions.
  
• Evaluate the efficacy and safety of nonpharmacologic and pharmacologic therapies for the management of fibromyalgia.

Who Will Benefit
This activity was designed to meet the continuing education needs of psychiatrists and other physicians. Other mental health professionals may find this activity informative and should check with their state licensing and certification boards to determine if it meets their continuing education requirements.

Your Distinguished Faculty

	Don L. Goldenberg, MD Chief of Rheumatology, Newton-Wellesley Hospital; Professor of Medicine, Tufts University School of Medicine; Director, Arthritis-Fibromyalgia Center of Newton-Wellesley Hospital
	Roy A. Kaplan, MD Assistant Clinical Professor, Department of Medicine, Division of Rheumatology, UCSD

Faculty Disclosures
Don L. Goldenberg, MD, is a member of the Speakers Bureau for Pfizer Inc. and Merck & Co., Inc. He also serves as a consultant for Pfizer Inc., Forest Pharmaceuticals, Inc., and Eli Lilly and Company.

Roy A. Kaplan, MD, is a member of the Speakers Bureau and a consultant for, and has received honorarium from, Abbott, Amgen, Wyeth Pharmaceuticals, Bristol-Myers Squibb Company, Centocor, and UCB.

Commercial Support

Supported by an educational grant from Eli Lilly and Company

Disclaimers
The content of this video activity may include product information that is inconsistent with or outside of the approved labeling for these products in the United States. Before prescribing any medication, you must familiarize yourself with the manufacturer's product information.

To earn continuing education credit, view this online course and complete the posttest and evaluation provided. A passing score of 75% or more must be achieved on the posttest. A link is provided within this online activity to access the posttest and evaluation. You will have the option of printing a CME Certificate for your records after submission of the evaluation.

CME LLC and are not responsible for the speaker's statements, materials, acts or omissions.

Continuing Medical Education
CME LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CME LLC designates this educational activity for a maximum of 1.25 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Content Originally Presented: 10/30/08; 9:30-10:45am
Online Date: 12/20/08
Credit Expiration Date: 12/20/09

This activity is based on the symposium Taking Psychiatry Beyond Mental Health: A Focus on Fibromyalgia onOctober 30, 2008 in San Diego, CA and may not reflect the most current data. Participants who attended the live symposium mentioned above cannot claim credit for this activity.